Optimizing the Total Cost of Ownership by C2 PHARMA's CEO, Andrew Badrot
All members of the pharmaceutical supply chain must implement reliable sourcing and manufacturing strategies that balance quality and costs to ensure the uninterrupted supply of high-quality medicines to patients worldwide.
” The production of safe and effective medicines requires access to reliable manufacturers of APIs. However, increasing pressure to reduce market prices of drugs has created deeper challenges for API sourcing organizations, often leading them to consider lower quality and less reliable suppliers. This is a short-sighted approach. Particularly as global quality standards become more harmonized, there are now higher expectations across the globe. And with COVID-19, reliability has also become a top-of-mind topic for manufacturers and healthcare systems. “
To read the full article, click the link Here!